Morgan Stanley expects Dr. Agarwal's revenue and Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) to ...

Morgan Stanley placed a target price of Rs 502 on Dr. Agarwal's Health Care stock, implying an upside potential of 17% to the previous close.

Dr Agarwal's Healthcare received modest response from investors. The IPO, which was subscribed just over 1.4 times, will see its share allotment get finalised later today. Investors can check Dr ...

If any of the displayed information needs updating, please click here. For concerns or queries regarding the information, feel free to email us. Medindia Constantly updates the database. However ...

An anchor lock-in refers to an investor being "locked" into a particular stock or investment due to a psychological or ...